The unique clinical spectrum of maturity onset diabetes of the young type 3.

[1]  A. Hattersley,et al.  Precision diabetes: learning from monogenic diabetes , 2017, Diabetologia.

[2]  K. Kvaløy,et al.  Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study , 2015, BMJ Open Diabetes Research and Care.

[3]  P. Heneberg,et al.  Low Frequencies of Autoimmunity-Associated PTPN22 Polymorphisms in MODY Patients, Including Those Transiently Expressing Islet Cell Autoantibodies , 2015, International Archives of Allergy and Immunology.

[4]  P. Heneberg,et al.  Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[5]  Aaron N. Winn,et al.  Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications , 2013, Diabetes Care.

[6]  O. Cinek,et al.  Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration , 2013, Diabetes Care.

[7]  T. Oron,et al.  The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent , 2012, Pediatric diabetes.

[8]  I. Fajardy,et al.  Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene , 2012, PloS one.

[9]  P. Bingley,et al.  Islet autoantibodies can discriminate maturity‐onset diabetes of the young (MODY) from Type 1 diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[10]  A. Hattersley,et al.  The diagnosis and management of monogenic diabetes in children and adolescents , 2009, Pediatric diabetes.

[11]  T. Reinehr,et al.  Phenotypical aspects of maturity‐onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[12]  M. Phillip,et al.  Childhood obesity complicating the differential diagnosis of maturity‐onset diabetes of the young and type 2 diabetes , 2007, Pediatric diabetes.

[13]  A. Hattersley,et al.  Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. , 2006, Human molecular genetics.

[14]  S. Rich,et al.  Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. , 2002, Diabetes care.

[15]  T. Frayling,et al.  Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers. , 2002, Diabetes care.

[16]  E. Lander,et al.  Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. , 1997, The Journal of clinical investigation.